Murphy's Medicine Podcast: Episode One. SARS CoV2 Associated Neurocognitive Decline
Covid Lists
SARS-Cov-2 Associated Neurocognitive Decline (SAND) Scan
Study Shows How Paxlovid Resistance Emerges in Persistent Infections
“This type of approach helped to improve HIV drugs, and we think it’s a good way to improve antivirals against SARS-CoV-2,” says Sho Iketani, PhD, assistant professor of medical sciences at Columbia University’s Vagelos College of Physicians and Surgeons and Aaron Diamond AIDS Research Center, who co-led the research with David D. Ho, MD, the Clyde '56 and Helen Wu Professor of Medicine, professor of microbiology & immunology, and director of the Aaron Diamond AIDS Research Center, and Haitao Yang, PhD, of ShanghaiTech University.
How monoclonal antibodies lost the fight with new COVID variants
Myocarditis complications more common after COVID infection than vaccination, 18-month data suggest | CIDRAP
COVID's Spike Protein Enhances Ability to Infect Brain - Neuroscience News
New vector vaccine against COVID-19 provides long-term protection
Postacute Sequelae of SARS-CoV-2 in Children
Long COVID Looks Different in Kids
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) - PubMed
Characterizing Long COVID in Children and Adolescents
Study determines most common long COVID symptoms in children and teens
Proof long Covid in kids DOES exist and they suffer worse symptoms
Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19.
Updated COVID Vaccines Are Coming: Effectiveness, Who’s Eligible And More
Project NextGen
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
University of Houston Researchers Create New Treatment and Vaccine for Flu and Various Coronaviruses
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models
Frontiers | NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines
Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study
Comparative Effectiveness of BNT162b2 and NVX-CoV2373 Vaccines in Korean Adults
Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs - Veterinary Research
Daniel Park_Novavax
12745679 - 2024.07.02.24309830v1.full.pdf
Short-Term Relative Effectiveness of Homologous NVX-CoV2373 and BNT162b2 COVID-19 Vaccinations in South Korea
Long COVID is a $1 trillion problem with no cure. Experts plead for governments to wake up - Carolyn Barber
COVID-19 in the Initiation and Progression of Atherosclerosis: Pathophysiology During and Beyond the Acute Phase
Prevalence of infection and reinfection among healthcare workers in a hospital of Northern China between BA.5/BF. 7 and XBB.1.5 wave
Pandemic Mitigation Collaborative - COVID-19 Forecasting Model